{"version":"1.0","type":"link","title":"A plain language summary of NALIRIFOX compared with nab-paclitaxel and gemcitabine for patients with metastatic pancreatic cancer (NAPOLI 3).","author_name":"Wainberg ZA 외","author_url":"https://prs-insight.online/author/Wainberg%20ZA","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/154143","thumbnail_width":1200,"thumbnail_height":630}